Bio-Thera Solutions, Ltd. (SHA:688177)
China · Delayed Price · Currency is CNY 23.70
-0.16 (-0.67%)
At close: Feb 13, 2026
Bio-Thera Solutions Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 845.17 | 743.01 | 704.41 | 455.13 | 836.58 | 182.86 |
Other Revenue | 0.15 | 0.15 | 0.38 | 0 | - | - |
| 845.32 | 743.17 | 704.79 | 455.13 | 836.58 | 182.86 | |
Revenue Growth (YoY) | 2.44% | 5.44% | 54.85% | -45.60% | 357.49% | 26023.37% |
Cost of Revenue | 204.01 | 229.7 | 194.67 | 191.09 | 35.9 | 19.92 |
Gross Profit | 641.31 | 513.46 | 510.13 | 264.04 | 800.68 | 162.95 |
Selling, General & Admin | 314.34 | 269.62 | 201.3 | 174.24 | 215.45 | 163.47 |
Research & Development | 735.17 | 777.63 | 768.64 | 616.39 | 543.42 | 562.65 |
Other Operating Expenses | 44.2 | 5.02 | 4.91 | 3.34 | 2.17 | 1.59 |
Operating Expenses | 1,094 | 1,053 | 975.04 | 793.26 | 761.93 | 727.82 |
Operating Income | -452.54 | -539.04 | -464.91 | -529.22 | 38.75 | -564.87 |
Interest Expense | -21.27 | -20.55 | -10.38 | -0.06 | -0.78 | -3.7 |
Interest & Investment Income | 6.07 | 4.98 | 8.3 | 15.53 | 21.68 | 18.3 |
Currency Exchange Gain (Loss) | 0.68 | 0.68 | -0.15 | 1.86 | 1.47 | 0.35 |
Other Non Operating Income (Expenses) | 3.35 | -0.25 | -0.33 | -0.26 | -0.39 | -0.47 |
EBT Excluding Unusual Items | -463.7 | -554.18 | -467.47 | -512.15 | 60.74 | -550.39 |
Gain (Loss) on Sale of Investments | 1.02 | 3.45 | 6.97 | 14.53 | 11.9 | 18.81 |
Gain (Loss) on Sale of Assets | -0.51 | -0.51 | 0.03 | -0.07 | -0.02 | -0.17 |
Asset Writedown | 0.06 | - | - | - | - | -0.13 |
Other Unusual Items | 94.51 | 40.94 | 66.05 | 17.29 | 18.42 | 18.67 |
Pretax Income | -368.63 | -510.3 | -394.42 | -480.4 | 91.04 | -513.23 |
Income Tax Expense | 0.21 | - | 0.11 | 0 | 9.11 | - |
Net Income | -368.84 | -510.3 | -394.53 | -480.4 | 81.94 | -513.23 |
Net Income to Common | -368.84 | -510.3 | -394.53 | -480.4 | 81.94 | -513.23 |
Shares Outstanding (Basic) | 414 | 415 | 415 | 414 | 410 | 404 |
Shares Outstanding (Diluted) | 414 | 415 | 415 | 414 | 410 | 404 |
Shares Change (YoY) | -0.15% | -0.10% | 0.28% | 1.09% | 1.38% | 16.97% |
EPS (Basic) | -0.89 | -1.23 | -0.95 | -1.16 | 0.20 | -1.27 |
EPS (Diluted) | -0.89 | -1.23 | -0.95 | -1.16 | 0.20 | -1.27 |
Free Cash Flow | -126.15 | -182.5 | -723.01 | -671.64 | 158.38 | -611.3 |
Free Cash Flow Per Share | -0.30 | -0.44 | -1.74 | -1.62 | 0.39 | -1.51 |
Gross Margin | 75.87% | 69.09% | 72.38% | 58.01% | 95.71% | 89.11% |
Operating Margin | -53.53% | -72.53% | -65.96% | -116.28% | 4.63% | -308.90% |
Profit Margin | -43.63% | -68.67% | -55.98% | -105.55% | 9.79% | -280.66% |
Free Cash Flow Margin | -14.92% | -24.56% | -102.58% | -147.57% | 18.93% | -334.30% |
EBITDA | -365.26 | -454.21 | -383.34 | -448.35 | 108.87 | -505.9 |
EBITDA Margin | -43.21% | -61.12% | -54.39% | -98.51% | 13.01% | -276.65% |
D&A For EBITDA | 87.27 | 84.83 | 81.57 | 80.88 | 70.12 | 58.98 |
EBIT | -452.54 | -539.04 | -464.91 | -529.22 | 38.75 | -564.87 |
EBIT Margin | -53.53% | -72.53% | -65.96% | -116.28% | 4.63% | - |
Effective Tax Rate | - | - | - | - | 10.00% | - |
Revenue as Reported | 845.32 | 743.17 | 704.79 | 455.13 | 836.58 | 184.99 |
Advertising Expenses | - | - | - | - | - | 7.77 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.